SCHEMBL3882733

SCHEMBL3882733

CNC(=O)c1cc(Oc2ccc3nc(NCCCc4cccc(O)c4)oc3c2)ccn1

nearest known ligand 0.55

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
BRAF P15056 18/20 0.55
RAF1 P04049 17/20 0.55
KDR P35968 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2676252 0.86 BRAF (0.60) BRAFRAF1KDR
SCHEMBL27738988 0.85 BRAF (0.62) BRAFRAF1KDR
SCHEMBL3878019 0.84 BRAF (0.56) BRAFRAF1KDR
SCHEMBL2675928 0.83 BRAF (0.61) BRAFRAF1KDR
SCHEMBL3879459 0.82 BRAF (0.60) BRAFRAF1KDR
SCHEMBL2676856 0.81 BRAF (0.57) BRAFRAF1KDR
SCHEMBL2676525 0.80 BRAF (0.54) BRAFRAF1KDR
SCHEMBL2675995 0.80 BRAF (0.60) BRAFRAF1KDR
SCHEMBL2676199 0.79 BRAF (0.64) BRAFRAF1KDR
SCHEMBL2676633 0.79 RAF1 (0.57) BRAFRAF1KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2010528-A2 6-O-SUBSTITUTED BENZOXAZOLE AND BENZOTHIAZOLE COMPOUNDS AND METHODS OF INHIBITING CSF-1R SIGNALING Novartis Pharma AG (CH) 2009-01-07 EP claimed
WO-2007121484-A2 6-O-SUBSTITUTED BENZOXAZOLE AND BENZOTHIAZOLE COMPOUNDS AND METHODS OF INHIBITING CSF-1R SIGNALING NOVARTIS AG (CH) 2007-10-25 WO claimed
EP-2010528-A2 6-O-SUBSTITUTED BENZOXAZOLE AND BENZOTHIAZOLE COMPOUNDS AND METHODS OF INHIBITING CSF-1R SIGNALING Novartis Pharma AG (CH) 2009-01-07 EP disclosed
WO-2007121484-A2 6-O-SUBSTITUTED BENZOXAZOLE AND BENZOTHIAZOLE COMPOUNDS AND METHODS OF INHIBITING CSF-1R SIGNALING NOVARTIS AG (CH) 2007-10-25 WO disclosed